LLY FY 2013 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2013 Earnings

Reported February 19, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$23.1B	—	$22.6B	—	2.3%
Op. Income	$5.5B	—	$5.0B	—	10.6%
Gross Margin	78.8%	—	78.8%	—	-0.0pp
Net Margin	20.3%	—	18.1%	—	2.2pp
EPS (Diluted)	$4.19	—	$3.57	—	17.4%
Free Cash Flow	$4.6B	—	$4.3B	—	8.9%

Revenue Flow

Item	Amount
REVENUE	$23.1B
Cost of Revenue	$4.9B
GROSS PROFIT	$18.2B
R&D Expenses	$5.5B
Selling & Marketing	$0
General & Administrative	$7.1B
SG&A Expenses	$7.1B
Other Expenses	$0
Operating Expenses	$12.7B
Cost & Expenses	$17.6B
OPERATING INCOME	$5.5B
Interest Income	$120M
Interest Expense	$160M
Other Income/Expenses	$341M
INCOME BEFORE TAX	$5.9B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$4.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.7B
D&A	$1.4B
EBIT	$6.0B
EBITDA	$7.5B
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$23.1B
Cost of Revenue	$4.9B
GROSS PROFIT	$18.2B
R&D Expenses	$5.5B
Selling & Marketing	$0
General & Administrative	$7.1B
SG&A Expenses	$7.1B
Other Expenses	$0
Operating Expenses	$12.7B
Cost & Expenses	$17.6B
OPERATING INCOME	$5.5B
Interest Income	$120M
Interest Expense	$160M
Other Income/Expenses	$341M
INCOME BEFORE TAX	$5.9B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$4.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.7B
D&A	$1.4B
EBIT	$6.0B
EBITDA	$7.5B
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$4.7B
Depreciation & Amortization	$1.4B
Stock-Based Compensation	$145M
Deferred Income Tax	$266M
Other Non-Cash Items	-$413M
Change in Working Capital	-$393M
OPERATING CASH FLOW	$5.7B
Capital Expenditure	-$1.1B
Acquisitions (Net)	-$44M
Purchases of Investments	-$15.6B
Sales/Maturities of Investments	$14.6B
Other Investing Activities	$800.0K
NET CASH FROM INVESTING	-$2.1B
Net Debt Issuance	-$11M
Common Stock Repurchased	-$1.7B
Common Dividends Paid	-$2.1B
Other Financing Activities	$0
NET CASH FROM FINANCING	-$3.8B
FREE CASH FLOW	$4.6B
Net Change in Cash	-$189M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.8B
Short-Term Investments	$1.6B
Net Receivables	$4.0B
Inventory	$2.9B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$13.1B
PP&E (Net)	$8.0B
Goodwill	$1.5B
Intangible Assets	$2.8B
Long-Term Investments	$7.6B
Tax Assets	$793M
Other Non-Current Assets	$1.4B
TOTAL NON-CURRENT ASSETS	$22.1B
TOTAL ASSETS	$35.2B
Account Payables	$1.1B
Short-Term Debt	$1.0B
Deferred Revenue	$0
Other Current Liabilities	$4.7B
TOTAL CURRENT LIABILITIES	$8.9B
Long-Term Debt	$4.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$4.5B
TOTAL NON-CURRENT LIABILITIES	$8.7B
TOTAL LIABILITIES	$17.6B
Common Stock	$699M
Additional Paid-In Capital	$5.0B
Retained Earnings	$17.0B
Treasury Stock	-$94M
Accum. Other Comp. Income	-$2.0B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$17.6B
Minority Interest	$9M
TOTAL EQUITY	$17.6B
TOTAL LIABILITIES & EQUITY	$35.2B
Total Debt	$5.2B
Net Debt	$1.4B